These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6126171)

  • 21. Desipramine plasma concentration and therapeutic response in elderly depressives: a naturalistic pilot study.
    Kutcher SP; Shulman KI; Reed K
    Can J Psychiatry; 1986 Nov; 31(8):752-4. PubMed ID: 3791131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression.
    Nelson JC; Price LH; Jatlow PI
    Am J Psychiatry; 1986 Sep; 143(9):1151-4. PubMed ID: 3752299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Desipramine (Petilil) in the treatment of depression].
    Rybakowski J; Jaracz J
    Psychiatr Pol; 1996; 30(6):993-1002. PubMed ID: 9132772
    [No Abstract]   [Full Text] [Related]  

  • 24. ECG effects of comparable plasma concentrations of desipramine and amitriptyline.
    Veith RC; Bloom V; Bielski R; Friedel RO
    J Clin Psychopharmacol; 1982 Dec; 2(6):394-8. PubMed ID: 7174862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible nonlinear pharmacokinetics of desipramine after once daily dosing.
    Amsterdam JD; Brunswick DJ; Potter L; Rickels K
    Pharmacopsychiatry; 1986 Mar; 19(2):84-7. PubMed ID: 3703927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Side effects of desipramine and age.
    Galanter CA; Bilich C; Walsh BT
    J Child Adolesc Psychopharmacol; 2002; 12(2):137-45. PubMed ID: 12188982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic symptoms in depression and antidepressants.
    Mathew RJ; Weinman ML; Thapar R; Reck JJ; Claghorn JL
    J Clin Psychiatry; 1983 Jan; 44(1):10-2. PubMed ID: 6822481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can yohimbine be used to treat orthostatic hypotension associated with the use of desipramine and other antidepressants? What general and/or specific strategy do you recommend for treating orthostatic hypotension?
    Price LH; Heninger GR
    J Clin Psychopharmacol; 1988 Oct; 8(5):384. PubMed ID: 3183081
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma desipramine levels and ECG changes in depressed young adults.
    Barnhill JG
    J Clin Psychopharmacol; 1992 Apr; 12(2):136-7. PubMed ID: 1573037
    [No Abstract]   [Full Text] [Related]  

  • 31. 2-Hydroxydesipramine and desipramine plasma levels and electrocardiographic effects in depressed younger adults.
    Stern SL; Ribner HS; Cooper TB; Nelson LD; Johnson MH; Suckow RF
    J Clin Psychopharmacol; 1991 Apr; 11(2):93-8. PubMed ID: 2056147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An assessment of drug-drug interactions: the effect of desvenlafaxine and duloxetine on the pharmacokinetics of the CYP2D6 probe desipramine in healthy subjects.
    Patroneva A; Connolly SM; Fatato P; Pedersen R; Jiang Q; Paul J; Guico-Pabia C; Isler JA; Burczynski ME; Nichols AI
    Drug Metab Dispos; 2008 Dec; 36(12):2484-91. PubMed ID: 18809731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients.
    Schenk PW; van Fessem MA; Verploegh-Van Rij S; Mathot RA; van Gelder T; Vulto AG; van Vliet M; Lindemans J; Bruijn JA; van Schaik RH
    Mol Psychiatry; 2008 Jun; 13(6):597-605. PubMed ID: 17667959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.
    Cooke RG; Warsh JJ; Stancer HC; Reed KL; Persad E
    Clin Pharmacol Ther; 1984 Sep; 36(3):343-9. PubMed ID: 6467794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine.
    Wilens TE; Biederman J; Baldessarini RJ; Puopolo PR; Flood JG
    J Am Acad Child Adolesc Psychiatry; 1992 Jul; 31(4):691-8. PubMed ID: 1644733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of antidepressant-induced side effects: a practical guide for the clinician.
    Pollack MH; Rosenbaum JF
    J Clin Psychiatry; 1987 Jan; 48(1):3-8. PubMed ID: 3804983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Side effects of methylphenidate and desipramine alone and in combination in children.
    Pataki CS; Carlson GA; Kelly KL; Rapport MD; Biancaniello TM
    J Am Acad Child Adolesc Psychiatry; 1993 Sep; 32(5):1065-72. PubMed ID: 8407753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
    Benazzi F
    J Psychopharmacol; 1997; 11(2):190-1. PubMed ID: 9208383
    [No Abstract]   [Full Text] [Related]  

  • 39. Desipramine plasma levels and response in elderly melancholic patients.
    Nelson JC; Jatlow PI; Mazure C
    J Clin Psychopharmacol; 1985 Aug; 5(4):217-20. PubMed ID: 4019810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the efficacy and safety of alprazolam and desipramine in depressed outpatients.
    Remick RA; Keller FD; Buchanan RA; Gibson RE; Fleming JA
    Can J Psychiatry; 1988 Oct; 33(7):590-4. PubMed ID: 3058290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.